Evidence map›Paper›PMID 31543998›Full record

ArticleBMJ global health2019

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance.

Christina M J E Vandenbroucke-Grauls, Gunnar Kahlmeter, Jan Kluytmans, Marjolein Kluytmans-van den Bergh, Dominique L Monnet, Gunnar Skov Simonsen, Robert L Skov, Ute Wolff Sönksen, Andreas Voss

Abstract readComment
In one paragraph

Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Christina M J E Vandenbroucke-GraulsMedical Microbiology & Infection Control, Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands.ORCID 0000-0003-2074-1597
Gunnar KahlmeterThe EUCAST Development Laboratory and Clinical Microbiology, Central Hospital in Vaxjo, Vaxjo, Sweden.
Jan KluytmansJulius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
Marjolein Kluytmans-van den BerghJulius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
Dominique L MonnetOffice of the Chief Scientist, European Centre for Disease Prevention and Control, Solna, Sweden.
Gunnar Skov SimonsenDepartment of Clinical Microbiology, University Hospital of North Norway, UiT Arctic University of Norway, Tromso, Norway.
Robert L SkovDivision of Infectious Disease Preparedness, Statens Serum Institut, Kobenhavn, Denmark.
Ute Wolff SönksenReference Laboratory for Antimicrobial Resistance, Infection Preparedness, Statens Serum Institut, Kobenhavn, Denmark.
Andreas VossDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic useantimicrobial resistanceDrug Resistance Index

Identifiers

PMID31543998
PMCPMC6730578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.